Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1/2 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 1041Neoplasms 872Prostatic Neoplasms 506Lung Neoplasms 421Colorectal Neoplasms 357Motor Activity 219Head and Neck Neoplasms 194Uterine Cervical Neoplasms 189Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 173Pancreatic Neoplasms 160Ovarian Neoplasms 138Colonic Neoplasms 137Carcinoma, Hepatocellular 136Anxiety Disorders 124Rectal Neoplasms 117Hematologic Neoplasms 114Multiple Myeloma 106Stomach Neoplasms 103Neoplasm Metastasis 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 94Melanoma 92Depression 92Urinary Bladder Neoplasms 88Pain 87Endometrial Neoplasms 86Glioblastoma 84Disease 83Lymphoma 81Sarcoma 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Neurofibromatosis 2 × 1 year × Clear all
NCT07420751 2026-04-28

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Massachusetts General Hospital

Phase NA Active not recruiting
18 enrolled
CNS

Neurofibromatosis 2, Hearing Loss

NCT03406208 2025-12-24

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

Massachusetts General Hospital

Phase NA Completed
228 enrolled
CNS

Schwannomatosis, Behavior, Neurofibromatosis 1, Neurofibromatosis 2, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡